Introduction
Cardiovascular diseases are collectively the leading causes of death in the United States, with diseases of the heart accounting for over 25% of all deaths in the United States [1] . Elevated circulating low-density lipoprotein (LDL) cholesterol has long been considered a risk factor for the development of atherosclerotic lesions, which may ultimately lead to impaired blood circulation, heart attacks and strokes. Several pharmaceutical and nutraceutical therapies are presently available to decrease LDL cholesterol, including the consumption of plant sterol and stanol esters (here, collectively referred to as phytosterol esters) [2] . Presently, one mechanism by which phytosterols are thought to exert their cholesterol-lowering effects is by decreasing the incorporation of cholesterol into micelles [3] , thereby decreasing absorption and increasing excretion of cholesterol [4] . In in vitro models, only free phytosterols are shown to be effective in displacing cholesterol [5] , while the physiological effects are demonstrated in vivo by both free and esterified phytosterols. This leads to the hypothesis that phytosterol esters must be hydrolyzed to impart their cholesterol-lowering effects, which is supported by the observation that supplementation of phytosterol esters increases the amounts of free phytosterols and cholesterol in feces [4] . Pancreatic cholesterol esterase (PCE; EC 3.1.1.13) has been suggested as the enzyme responsible for the hydrolysis of phytosterol esters. To date, however, no research has been conducted to confirm whether PCE hydrolyzes these esters, much less whether PCE selectively hydrolyzes various sterol esters.
Efficient absorption of dietary cholesterol esters is dependent on hydrolysis by PCE, followed by the subsequent solubilization of free cholesterol by gall bladder secretions to form mixed micelles in the intestinal lumen; free phytosterols are also solubilized in this way [5] . Furthermore, the putative intestinal cholesterol transporter Niemann-Pick C1-Like 1 (NPC1L1) transports free sterols but not sterol esters [6] . Thus, it appears that the hydrolysis of cholesterol esters is necessary for the cholesterol from these esters to be efficiently micellarized and absorbed, while hydrolysis of phytosterol esters may be necessary to impart their cholesterollowering properties.
PCE is a broad lipid-ester hydrolase, hydrolyzing other lipid carboxyl esters in addition to cholesterol esters [7, 8] . The hydrolytic activity is not uniform across substrates, however, as the diacylglycerol lipase activity of PCE is greater than its triacylglycerol lipase activity [7] , and the phospholipase A1 activity of PCE is greater than its phospholipase A2 activity [8] .
Because of the documented differences in substrate specificities, we hypothesized that PCE hydrolyzes phytosterol esters, and that the rate of hydrolysis depends on both the sterol and fatty acid moieties.
Methods and Materials

Reagents
Stigmasterol (95%) and stearoyl chloride (90%) were purchased from TCI America (Portland, OR, USA). Sitosterol (75%), cholesteryl stearate (96%), cholesteryl palmitate (97%) and palmitoyl chloride (98%) were purchased from ACROS Organics (Geel, Belgium). Oleoyl chloride (85%), sodium cholate hydrate (99%), cholesteryl oleate (98%), oleic acid (99%), stearic acid (99%), Sylon BTZ and palladium on carbon (Pd/C, 10%) were purchased from Sigma-Aldrich (St. Louis, MO, USA). 5α-Cholestane was obtained from Steraloids (Newport, RI, USA). Cholesterol (95%) was obtained from Mallinckrodt OR (Paris, KY, USA). W2 Raney Nickel (RaNi) was prepared by reaction of NiAl 2 alloy and NaOH as previously described [9] . Palmitic acid (99+%), Triton X-100 and porcine pancreatic cholesterol esterase (Cat. no. 0215067180) were obtained from MP Biomedicals (Irvine, CA, USA). PCE contained the trace enzyme contaminants of 0.0098% chymotrypsin, < 0.0004% glucose oxidase, 0.432% trypsin and < 0.0001% uricase, as determined by the manufacturer, none of which should alter lipid metabolism.
Phytosterol ester preparation
Stigmasterol was used as supplied by the manufacturer in subsequent preparations.
Stigmastanol (a.k.a. sitostanol) was prepared from stigmasterol as previously described [10, 11] . Briefly, 1.06 g (1 mmol) of Pd/C was added to 400 ml of a 45 mM stirred solution of stigmasterol in 2-propanol. The reaction mixture was stirred under an atmosphere (balloon) of hydrogen gas at 60°C overnight, after which the Pd/C was removed by filtration through a pad of Celite. The resulting solution was concentrated at reduced pressure to provide a quantitative yield of pure stigmastanol (mp 139-140°C; literature 140°C [12] ). The lack of a residual alkene was verified by 1 H NMR.
Sitosterol of relatively high purity (92%) was prepared through a threestep procedure [10] . First, 4.4 g (10 mmol) of stigmasterol were hydrogenated using 3.4 g RaNi in 350 ml of ethyl acetate under an atmosphere (balloon) of hydrogen gas; the reduction step was monitored by gas chromathography/mass spectrometry, using an AT-5 column (Alltech Associates, Deerfield, IL, USA; 0.32 mm×30 m). Once the hydrogenation had consumed most of the stigmasterol (typically 10 h), the RaNi was removed by filtration through a pad of Celite and the solvent was removed at reduced pressure. The crude residue was analyzed by 1 H NMR and determined to consist of a 7:80:13 mixture of stigmasterol, sitosterol and stigmastanol, based upon the relative integration of the signals at 0.720, 0.702 and 0.671 ppm, respectively. Second, the mixture of sterols was dissolved in 100 ml of ether and treated dropwise with 20 ml of 0.6 M bromine in ether at room temperature. The reaction flask was then stoppered and stored at −20°C for 3 days. Crystals, which were residual stigmastanol (confirmed by TLC), were removed by filtration and the filtrate was concentrated in vacuum. The residue was purified by flash column chromatography with 10% ethyl acetate in hexane to furnish sitosterol 5,6-dibromide. Third, the dibromide was refluxed with 100 ml of 340 mM excess zinc in 1:1 ethanol:acetic acid for 3 h. Solvent was removed, and 50 ml of water was added; the suspension was extracted with three washes of 50 ml of dichloromethane. The organic layer was dried over sodium sulfate and solvent was removed under reduced pressure. The residue was recrystallized from hot acetone to furnish sitosterol as a white solid (mp 137-138°C; literature: 139°C [12] ). The sitosterol obtained (1.2 g, 29% yield) was determined to be 92% pure based upon 1 H NMR with impurities of stigmasterol (5%) and stigmastanol (3%).
Each phytosterol ester was generated as follows (illustrated for sitosteryl palmitate): 5.4 mmol of palmitoyl chloride were added dropwise to a stirred mixture of 3.6 mmol of sitosterol and 0.95 mmol dimethylaminopyridine in 20 ml of dry pyridine at 50°C. The temperature was then increased to 70°C and stirred overnight. The reaction was cooled and diluted with 100 ml of water. The resulting suspension was acidified to a pH of 3-4 with 3 M HCl and subsequently extracted with three washes of 100 ml of dichloromethane. The combined organic layers were dried over sodium sulfate and solvent was removed under reduced pressure. The residue was recrystallized from hot ethyl acetate to furnish sitosteryl palmitate (2.2 g, 88% yield) as a white solid (mp 79-80°C; literature: 85.5°C [12] ). Analysis by 1 H NMR suggested the sitosteryl palmitate was 92% pure and contained approximately 8% of a mixture of stigmasteryl and stigmastanyl palmitates.
PCE activity assay
Lyophilized PCE (100 U) was dissolved in 1 ml of 100 mM potassium phosphate buffer at pH 7.0 as recommended by the manufacturer, separated into 200 μl aliquots and stored at −80°C until ready to use. Prior to use, an aliquot was thawed on ice and diluted to 2 U/ml of the same buffer. The stability of thawed PCE was determined by storing thawed PCE at 4°C for 0, 5, or 7 days. The hydrolytic activity of the enzyme was tested on aliquots of the same solubilized cholesteryl oleate solution and incubated as described later, with hydrolysis being measured as the appearance of free cholesterol by gas chromathography (GC). No changes in activity were seen after 7 days (data not shown); regardless, freshly thawed enzyme was used when possible.
A routine enzyme assay was developed and validated to test the substrate specificity of PCE. Sterol esters (8 μmol) were dissolved in chloroform and added to 16×100-mm glass, screw-top tubes, and solvent was evaporated under N 2 at 50°C. Sodium cholate hydrate (100 mg), Triton X-100 (1 ml) and deionized water (8 ml) were added and tubes were capped with PTFE-lined lids. The solution was heated and stirred with a stir bar to 100°C until the solution turned white. Solutions were removed from heat and slowly cooled to 60°C with stirring, after which 1 ml of a 1 M, pH 7.0 potassium phosphate buffer was added. The final composition of the mixture was 10 ml of 800 μM sterol ester, 1% (w/v) sodium cholate, 100 mM phosphate buffer and 10% (v/v) Triton X-100. The optimal pH of the assay was determined to be 7.0 after testing a pH range of 6.0-8.0 (see results). Solutions remained transparent with no sedimentation throughout the incubation periods. Using cholesteryl oleate, this mixture was demonstrated to produce a micelle when separated using high performance gel filtration, as previously described by Cohen and Carey [13] and modified by Jesch and Carr [14] (data not shown).
The effects of hydrolysis products on the hydrolysis of cholesteryl oleate by PCE under different simulated conditions were determined by adding unesterified stearic, palmitic or oleic acids or cholesterol, sitosterol, stigmasterol or stigmastanol to solubilized cholesteryl oleate: 0.8 mM individual fatty acids were incorporated into the test system to simulate the fatty acids present from 100% hydrolysis of test substrates; 16 mM individual fatty acids were used to test the effects of a larger ratio of free fatty acids to sterol ester, such as that present in duodenal contents in the fed state; 2.4 mM free sterol was used to approximate the 3:1 ratio of the Food and Drug Administration (FDA)'s recommended daily consumption of phytosterols as esters (1.3 g/day phytosterol esters ≈ 2 mmol phytosterols) [15] to average cholesterol consumed (257 mg/day ≈ 0.66 mmol cholesterol) [16] .
Aliquots of each solubilized sterol ester (0.5 ml) were added to separate glass screw top tubes and preheated to 37°C. Dilute PCE (20 μl; 0.04 U) was added to each tube. Reactions were incubated at 37°C on a rocking platform. Hydrolysis, as measured by the appearance of free sterol or stanol by GC, proved to be linear through 16 min of incubation with R 2 > 0.99 for each sterol ester; therefore, subsequent incubation times were 8 min to ensure sampling from the linear range of the reaction. Hydrolysis was stopped and lipids were extracted by Folch lipid extraction [17] by addition of 2 ml of ice cold 2:1 chloroform:methanol (v/v) containing 50 μM 5α-cholestane as an internal standard for GC analysis. Stopped reaction mixtures were vortexed for 10 s and centrifuged at room temperature at 1000×g for 10 min; the aqueous supernatant was aspirated and discarded. The chloroform in the infranatant was evaporated under nitrogen gas at 50°C; 1 ml of hexanes was then added to each sample, samples were vortexed and the samples were again centrifuged at 1000×g for 10 min. The hexanes-soluble supernatant was transferred to a GC vial, while any residual aqueous layer remained in the infranatant. Hexanes were evaporated at 50°C under nitrogen gas; trimethylsyl derivatives were prepared by addition of 100 μl of Sylon BTZ to each dried sample and subsequently transferred to a 300 μl GC vial insert. GC vials were capped using PTFE septa, and samples were allowed to derivatize for at least 30 min. Samples were analyzed by GC using an AT-5 column (Alltech Associates).
Statistics
Cholesteryl oleate hydrolysis by PCE was used as an external standard for each set of reactions. Relative activities were calculated by dividing the rate of hydrolysis of individual sterol esters by the within-set hydrolysis of cholesteryl oleate. Statistics were computed using the mixed procedure of SAS software (version 9.1; SAS Institute, Cary, NC, USA). A two-way analysis of variance using sterol and fatty acid moieties as fixed effects was computed. Least squares means were calculated, and between-sterol and between-fatty acid comparisons were analyzed, as well as individual interaction terms of sterol esters, using the "/pdiff" option of "lsmeans." Bonferroni corrections were made to account for multiple comparisons.
Results
Method validity
Cholesteryl oleate was most effectively hydrolyzed at pH 7.0, with pH 6.0, 6.5, 7.5 and 8.0 retaining 89%, 80%, 84% and 72% activity, respectively, relative to pH 7.0. Thus, all subsequent experiments were performed at pH 7.0. In addition, no appreciable ester synthesis was observed when PCE was added to a solution of cholesterol and oleic acid (data not shown). Storage of PCE for up to 7 d at 4°C did not alter its activity when measured at 8 and 16 min incubations (data not shown). These preliminary experiments ensure that the hydro-lytic capabilities of PCE did not change over the course of a set of incubations because freshly thawed PCE was used for incubations whenever possible and was never used when stored at 4°C for more than 2 days.
Optimal incubation times were determined by incubating aliquots of a solution of cholesteryl oleate for 0, 0.25, 0.5, 1, 2, 4, 8, 15, 30 and 60 min (Figure 1) . Shorter incubation times, specifically at 0.25 and 0.5 min (Figure 1 inset) , had higher error among replicates and did not fit the overall curve well; longer incubation times, specifically at 30 and 60 min, were beyond the linear region necessary for determining the initial velocity of the reactions. Therefore, subsequent serial reactions for each solubilized sterol ester were conducted with incubation times of 0, 1, 2, 4, 8 and 16 min ( Figure 2) ; hydrolysis was linear for each ester through 16 min. To ensure sampling from the linear range of the reaction, replicate hydrolysis measurements used only the 8-min time point to determine the initial velocity of the reaction.
Substrate Specificity
The rate of hydrolysis was affected by both the sterol and the fatty acid portions of the sterol esters. The average rate of hydrolysis of cholesterol esters was significantly greater than the average rate of hydrolysis of the esters of the three phytosterols ( Figure 3 ; sterol effect: P < .0001). Stigmastanol and sitosterol esters were hydrolyzed statistically equally (56.4±1.2% and 58.9±1.2%, respectively, normalized to cholesterol esters), though more efficiently than stigmasterol esters (29.3±1.3%). Additionally, the rate of hydrolysis of sterol esters was significantly affected by the fatty acid moiety (Figure 3 ; ester effect: P < .0001). Oleate esters, on average, were hydrolyzed most efficiently, while palmitate and stearate esters were hydrolyzed statistically equally (45.8±1.0% and 41.6±1.1%, respectively, normalized to oleate esters).
The sterol and ester effects synergistically affected rates of hydrolysis when specific sterol esters were considered (Figure 3 ; Figure 1 . Confirming kinetic properties of PCE in the experimental assay conditions. Cholesteryl oleate was solubilized at a concentration of 800 μM in a 100 mM, pH 7.0 phosphate buffer containing 1% (w/v) sodium-cholate and 10% (v/v) Triton X-100 and hydrolyzed with PCE at 37°C for the times indicated on the x-axis. Progression of hydrolysis was measured by the appearance of free cholesterol. Data points represent one replicate, and are fit with a Michaelis-Menten curve. Inset: Close-up of incubation times less than 5 min.
Figure 2.
Determining the linear region of hydrolysis by PCE in the experimental assay conditions. Solubilized sterol esters at a concentration of 800 μM were hydrolyzed by PCE at 37°C for the times denoted on the x-axis. Hydrolysis was measured by the appearance of the respective free sterols. For clarity, only cholesterol esters and the oleate esters of the phytosterols are shown, though palmitate and stearate esters of the three phytosterols tested were similarly linear. Data points represent the means of two replicates. Solubilized sterol esters at a concentration of 800 μM were incubated in the presence of PCE at 37°C for 8 min. Hydrolysis was measured by the appearance of the respective free sterols. Cholesteryl oleate was used as an external standard for each set of reactions and the average hydrolysis of cholesteryl oleate was set to 100% for each set of replicates. Bars represent means ± SEM; n = 4-6 for all esters except cholesteryl oleate with n = 18. Bars without common letters differ by a Bonferroni adjusted P < .05. interaction effect: P < .0001). In all cases, oleate esters were hydrolyzed more efficiently than the palmitate and stearate esters of the same sterol. Further, with the exception of stigmastanyl stearate, hydrolysis of sterol esters was in the order of cholesterol > (stigmastanol = sitosterol) > stigmasterol esters within a particular acyl group; stigmastanyl stearate was hydrolyzed to the same extent as stigmasteryl stearate.
Across all sterol esters tested, cholesteryl oleate was hydrolyzed most effectively, while stigmasteryl palmitate and stearate were hydrolyzed the least effectively (12.9±1.3% and 12.6±1.6%, respectively, normalized to cholesteryl oleate). Among phytosterol esters, stigmastanyl oleate and sitosteryl oleate were statistically equally hydrolyzed at a greater rate than the other phytosterol esters tested (64.2±1.3% and 59.8±1.3%, respectively, normalized to cholesteryl oleate).
In an attempt to determine if the differences in rates of hydrolysis were the result of inhibition or activation of PCE by hydrolysis products, free sterols or free fatty acids were added to a solution of cholesteryl oleate. Creating a three-to-one ratio of free sterols to cholesteryl oleate did not affect hydrolysis (Figure 4) , nor did the addition of equimolar free fatty acids affect hydrolysis (data not shown). However, hydrolysis appeared to be stimulated when a larger ratio of free fatty acids to sterol esters was used ( Figure 5 ).
Discussion
Disrupting cholesterol micellarization and absorption in the intestine have been targets for decreasing cholesterol concentrations in the circulation. Ezetimibe, an inhibitor of NPC1L1 [18] , and isocoumarin-derived compounds used to inhibit PCE [19] are just two examples of pharmaceutical manipulation of cholesterol absorption with the intent of decreasing atherosclerotic risk. At the forefront of nutraceutical therapies, phytosterols and their esters have been effective in altering intestinal sterol metabolism, though the complete characterization of their mechanisms of action has been elusive. In the present study, we created an in vitro model to investigate the hydrolysis of selected sterol esters by PCE and determined that PCE is capable of hydrolyzing a variety of sterol esters at various rates.
The first consideration in creating our model system was to solubilize sterol esters in an aqueous system devoid of other potential substrates for PCE. PCE is a fairly indiscriminant carboxyl ester hydrolase, capable of hydrolyzing many of the lipids that are used in typical micelle preparations and that exist in micelles in vivo, including phospholipids [7] and acyl glycerols [8] . Furthermore, PCE has been reported to catalyze the reverse reaction of ester synthesis [20] , prompting us to create an aqueous model devoid of free fatty acids to avoid encouraging the reverse reaction of ester synthesis by altering the equilibrium.
To avoid using free fatty acids, acyl glycerols or phospholipids as amphipathic detergents, we chose to use Triton X-100 [21] .
Other considerations for the model system included satisfying the bile salt dependency of PCE, and, in particular, the preference for a trihydroxy, rather than dihydroxy, bile salt [22] , which was satisfied by the addition of sodium cholate; the potential for pH to affect the hydrolytic capability of PCE [23] ; the potential for concurrent production and hydrolysis of sterol esters, which may have been prevented by the addition of greater than 20mM sodium cholate [24] and the ability to solubilize all esters at equal concentrations. We not only addressed these concerns but validated that PCE can perform enzymatic hydrolysis in our model system in a reproducible manner.
Once the model hydrolysis system was validated, we demonstrated that PCE, in addition to hydrolyzing various sterol esters, exhibited substrate specificity that was affected both by the sterol and fatty acid portions of the ester. Saturated esters were less well hydrolyzed than the unsaturated ester, with the within-sterol palmitate and stearate esters being hydrolyzed approximately 40% as well as the oleate ester. A similar disparity was demonstrated with a cholesterol esterase derived from rat testis, where cholesteryl stearate was hydrolyzed only 25% as well as cholesteryl oleate [25] . Substrate specificity of PCE also appeared to be affected by certain structural elements of the individual sterols. The ethyl substitution on carbon 24 of the phytosterols is the consistent structural difference between the phytosterols and cholesterol, and the phytosterol esters were consistently hydrolyzed less efficiently than cholesterol esters. The inclusion of the delta 22 double bond, which is the only structural difference between sitosterol and stigmasterol, coincided with a significant decrease in the relative activity of PCE. However, the presence or absence of the delta five double bond, the only structural difference between sitosterol and stigmastanol, appeared to have little effect on the hydrolytic ability of PCE as evidenced by the similar hydrolysis when sitosterol and stigmastanol esters are compared. Thus, it could be that small changes to the side chain bonded to carbon 17 of these sterols may be more integral in conferring substrate specificity of PCE than the cyclic structure, though this would need to be confirmed by the hydrolysis of other sterol esters.
An unexpected result of this study was the increased hydrolysis of cholesteryl oleate observed upon addition of larger concentrations of free fatty acids. The ratio of free fatty acids to sterol ester in these experiments roughly approximated 50% hydrolysis of the average consumption of dietary triacylglycerols [16] to the FDA's recommended intake of phytosterol esters [15] , thus approximating the initial duodenal contents of these components in the fed state. All three fatty acids increased the hydrolysis of cholesteryl oleate as compared with the solution initially devoid of fatty acids. Although not demonstrated statistically, it appeared that the more hydrophobic fatty acids promoted greater increases in PCE activity. An explanation of the activation of PCE by these fatty acids could be the formation of a more native lipid emulsion with which PCE could interact, such as that which may exist when free fatty acids are present in the duodenum in the fed state. This hypothesis is supported by the observations of Nissinen et al. [26] that only 40% of plant stanol esters were hydrolyzed in vivo on a low fat diet versus 70% on a normal fat diet.
Precedence exists for mammalian systems to distinguish between cholesterol and plant sterols, including the higher rate of plant sterol efflux via ABCG5/G8 cotransporters [27] and the higher rate of esterification of cholesterol as compared with sitosterol in the cytosol of proximal rat intestinal cells [28] . Several human studies have also indicated a potential for discrimination among various sterols. In colectomized patients, ingested cholesterol esters were almost completely hydrolyzed (95%) by the time they reached the feces, while 90% of sitosterol esters and only 57% of stigmastanol es- ters were hydrolyzed [26] . In another study, the effects of phytosterol esters on proximal digestion and absorption were isolated using duodenal infusion of solubilized sterols and sterol esters and measuring the composition in the proximal jejunum. The percentage of esterified sitosterol dropped from 64% to 27% and esterified stigmastanol from 92% to 39% from infusion to the proximal jejunum [29] . While these studies support the present findings, confounding factors such as exposure to multiple digestive enzymes, variable emulsion structures and diverse concentrations of substrates have made it impossible to conclusively determine the hydrolytic activity of PCE alone.
The interaction of phytosterol esters with PCE alone has the potential to decrease the hydrolysis of dietary cholesterol esters via competitive inhibition and thereby decrease the absorption of the free cholesterol derived from cholesterol esters. However, only a small portion of dietary cholesterol is in the esterified form [14] ; furthermore, the effects of phytosterol esters are demonstrated whether consumed only once daily or multiple times daily [30] , which indicates that competition for PCE is likely not the only mechanism of action for phytosterols. Because the hydrolysis of cholesterol esters would only minimally add to the total cholesterol in the duodenum, competitive inhibition experiments were not conducted in this study.
Here, we have used an in vitro model to demonstrate the potential for vastly different efficacies of phytosterol ester supplementation on cholesterol absorption that depends on phytosterol ester structure. However, it is unknown if the in vitro hydrolysis of phytosterol esters reflects hydrolysis in vivo, nor is it known by what mechanisms phytosterol ester supplementation most effectively decreases plasma cholesterol. Several proposed mechanisms include phytosterols interacting with cholesterol transporters, competing with cholesterol for micellar solubility, regulating cholesterol-related genes and interacting with digestive enzymes [14] . The evidence supporting these mechanisms often has not explored whether phytosterol esters or free phytosterols are most effective at inhibiting cholesterol absorption. The present study demonstrated that phytosterol esters interact with at least one digestive enzyme, PCE, while free phytosterols show no effect on cholesterol ester hydrolysis, helping to further understand the mechanisms behind the ability of phytosterol and phytosterol ester supplementation to inhibit cholesterol absorption.
